RxDoctor Payments Data

Ruoyu Miao, MD

Hematology & Oncology · Atlanta, GANPI 1568967149

Payments from drug & device makers

$6,685in general payments, 2019–2025

Across 29 payments — averaging $230.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim Pharma GmbH & Co.kg$5K
  • Boehringer Ingelheim$988
  • Boehringer Ingelheim International GmbH$326
  • Astellas Pharma US Inc$283
  • Pfizer$82
  • Seagen Inc.$45
  • plus $101 from 3 others

What the payments were for

  • Food & beverage$24548%
  • Education$26652%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,685 in reported general payments places this provider in the 45th percentile of 370 hematology & oncology providers in Georgia.

See all hematology & oncology providers in Georgia

Medicare billing

Part B allowed, 2024
$2,324
Medicare patients
11
Services billed
18

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →